Darrell Hs Tan

Summary

Publications

  1. doi request reprint Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act
    Robert W Burgoyne
    Immunodeficiency Clinic, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Canada M5G 2C4
    J Antimicrob Chemother 61:469-73. 2008
  2. pmc Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
    Dhs Tan
    Divisions of Infectious Diseases, St Michael s Hospital, University, Health Network, and University of Toronto, Toronto, Canada
    Int J Womens Health 4:341-50. 2012
  3. pmc Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies
    Darrell Hoi San Tan
    Division of Infectious Diseases, St, Michael s Hospital, 30 Bond St, 4CC Room 4 179, Toronto, ON M5B 1W8, Canada
    BMC Infect Dis 13:502. 2013
  4. pmc Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009
    Ann N Burchell
    Ontario HIV Treatment Network, Suite 600, 1300 Yonge Street, Toronto, Ontario M4T 1X3, Canada
    BMC Infect Dis 13:246. 2013
  5. doi request reprint Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection
    Darrell H S Tan
    St Michael s Hospital, Division of Infectious Diseases, 30 Bond St, 4CC Rm 4 179, Toronto, ON M5B 1W8, Canada
    Clin Infect Dis 57:448-57. 2013
  6. doi request reprint Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit
    Darrell H S Tan
    Division of Infectious Diseases, University Health Network, Faculty of Medicine, University of Toronto, 585 University Avenue, 13 N, Toronto, Ontario M5G 2N2, Canada
    Crit Care Clin 29:603-20. 2013
  7. ncbi request reprint Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature
    Darrell H S Tan
    Division of Infectious Diseases, University Health Network, Toronto, ON
    Clin Infect Dis 45:e72-6. 2007
  8. ncbi request reprint Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections
    Darrell Tan
    Division of Infectious Diseases, University of Toronto, Toronto, Canada
    Expert Rev Anti Infect Ther 5:13-28. 2007
  9. doi request reprint No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults
    Darrell Hs Tan
    University Health Network Division of Infectious Diseases, Canada bUniversity of Toronto, Ontario, Canada
    AIDS 25:207-10. 2011
  10. pmc Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
    Darrell H S Tan
    University Health Network, 585 University Ave, 13N 1323, Toronto, Ontario, M5G 2N2 Canada
    Trials 11:113. 2010

Detail Information

Publications12

  1. doi request reprint Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act
    Robert W Burgoyne
    Immunodeficiency Clinic, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Canada M5G 2C4
    J Antimicrob Chemother 61:469-73. 2008
    ..This article reviews research findings on treatment and QOL outcomes a decade into the HAART era...
  2. pmc Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
    Dhs Tan
    Divisions of Infectious Diseases, St Michael s Hospital, University, Health Network, and University of Toronto, Toronto, Canada
    Int J Womens Health 4:341-50. 2012
    ..This article reviews the currently available data for tenofovir as an anti-herpes agent, as well as unanswered questions about delivery systems, drug formulation, rectal administration, drug resistance, and clinical applications...
  3. pmc Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies
    Darrell Hoi San Tan
    Division of Infectious Diseases, St, Michael s Hospital, 30 Bond St, 4CC Room 4 179, Toronto, ON M5B 1W8, Canada
    BMC Infect Dis 13:502. 2013
    ..Herpes simplex virus type 2 (HSV-2) is a common co-infection among HIV-infected adults that is hypothesized to accelerate HIV disease progression...
  4. pmc Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009
    Ann N Burchell
    Ontario HIV Treatment Network, Suite 600, 1300 Yonge Street, Toronto, Ontario M4T 1X3, Canada
    BMC Infect Dis 13:246. 2013
    ..We characterized temporal patterns of of syphilis testing in a large cohort of HIV patients in Ontario, Canada...
  5. doi request reprint Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection
    Darrell H S Tan
    St Michael s Hospital, Division of Infectious Diseases, 30 Bond St, 4CC Rm 4 179, Toronto, ON M5B 1W8, Canada
    Clin Infect Dis 57:448-57. 2013
    ..We compared rates of CD4 count decline according to HSV-2 status in untreated HIV-infected adults...
  6. doi request reprint Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit
    Darrell H S Tan
    Division of Infectious Diseases, University Health Network, Faculty of Medicine, University of Toronto, 585 University Avenue, 13 N, Toronto, Ontario M5G 2N2, Canada
    Crit Care Clin 29:603-20. 2013
    ..In this article, the epidemiology of HIV-related ICU admission is reviewed and key management issues are discussed. ..
  7. ncbi request reprint Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature
    Darrell H S Tan
    Division of Infectious Diseases, University Health Network, Toronto, ON
    Clin Infect Dis 45:e72-6. 2007
    ..Recognition of these syndromes is important to avoid unnecessary antibiotic use...
  8. ncbi request reprint Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections
    Darrell Tan
    Division of Infectious Diseases, University of Toronto, Toronto, Canada
    Expert Rev Anti Infect Ther 5:13-28. 2007
    ..Its favorable pharmacological and clinical characteristics have recently prompted investigators to explore its potential novel applications in HIV monotherapy and double-boosted regimens...
  9. doi request reprint No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults
    Darrell Hs Tan
    University Health Network Division of Infectious Diseases, Canada bUniversity of Toronto, Ontario, Canada
    AIDS 25:207-10. 2011
    ..to determine the impact of oral tenofovir as part of combination antiretroviral therapy on asymptomatic herpes simplex virus (HSV) shedding...
  10. pmc Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
    Darrell H S Tan
    University Health Network, 585 University Ave, 13N 1323, Toronto, Ontario, M5G 2N2 Canada
    Trials 11:113. 2010
    ..Suppression of herpes simplex virus type 2 (HSV-2) may be a novel strategy for achieving this goal because HSV-2 is associated with clinically significant increases in HIV viral load, the primary driver of HIV disease progression...
  11. ncbi request reprint Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors
    Darrell Tan
    Division of Infectious Diseases, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4
    HIV Clin Trials 7:107-15. 2006
    ..This cross-sectional study evaluated whether an association exists between mild symptoms and lactate levels...